Weeraratna AT - Search Results

1

Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.

Camilli TC, Xu M, O'Connell MP, Chien B, Frank BP, Subaran S, Indig FE, Morin PJ, Hewitt SM, Weeraratna AT. Camilli TC, et al. Among authors: weeraratna at. Pigment Cell Melanoma Res. 2011 Feb;24(1):175-86. doi: 10.1111/j.1755-148X.2010.00792.x. Epub 2010 Dec 1. Pigment Cell Melanoma Res. 2011. PMID: 20955350 Free PMC article.

2

Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.

Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM. Weeraratna AT, et al. Cancer Cell. 2002 Apr;1(3):279-88. doi: 10.1016/s1535-6108(02)00045-4. Cancer Cell. 2002. PMID: 12086864 Free article.

3

Wnt signaling in human cancer.

Morin PJ, Weeraratna AT. Morin PJ, et al. Among authors: weeraratna at. Cancer Treat Res. 2003;115:169-87. doi: 10.1007/0-306-48158-8_7. Cancer Treat Res. 2003. PMID: 12613197 Review. No abstract available.

4

The APC tumor suppressor pathway.

Morin PJ, Weeraratna AT. Morin PJ, et al. Among authors: weeraratna at. Methods Mol Biol. 2003;222:21-40. doi: 10.1385/1-59259-328-3:021. Methods Mol Biol. 2003. PMID: 12710678 No abstract available.

5

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, Schwartz DR, Shock T, Morin PJ. Sherman-Baust CA, et al. Among authors: weeraratna at. Cancer Cell. 2003 Apr;3(4):377-86. doi: 10.1016/s1535-6108(03)00058-8. Cancer Cell. 2003. PMID: 12726863 Free article.

6

Serial analysis of gene expression (SAGE): advances, analysis and applications to pigment cell research.

Weeraratna AT. Weeraratna AT. Pigment Cell Res. 2003 Jun;16(3):183-9. doi: 10.1034/j.1600-0749.2003.00042.x. Pigment Cell Res. 2003. PMID: 12753384

7

Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome.

Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ, Wagner U, Kallioniemi OP, Trent JM, Morin PJ, Meltzer PS. Weeraratna AT, et al. Oncogene. 2004 Mar 18;23(12):2264-74. doi: 10.1038/sj.onc.1207337. Oncogene. 2004. PMID: 14755246

8

A Wnt-er wonderland--the complexity of Wnt signaling in melanoma.

Weeraratna AT. Weeraratna AT. Cancer Metastasis Rev. 2005 Jun;24(2):237-50. doi: 10.1007/s10555-005-1574-z. Cancer Metastasis Rev. 2005. PMID: 15986134 Review.

9

Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.

Li J, Wood WH 3rd, Becker KG, Weeraratna AT, Morin PJ. Li J, et al. Among authors: weeraratna at. Oncogene. 2007 May 3;26(20):2860-72. doi: 10.1038/sj.onc.1210086. Epub 2006 Oct 30. Oncogene. 2007. PMID: 17072341

10

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ, Weeraratna AT. Leotlela PD, et al. Among authors: weeraratna at. Oncogene. 2007 May 31;26(26):3846-56. doi: 10.1038/sj.onc.1210155. Epub 2006 Dec 11. Oncogene. 2007. PMID: 17160014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters